Vaxxinity Faces Nasdaq Delisting Over Share Price
Company Announcements

Vaxxinity Faces Nasdaq Delisting Over Share Price

Vaxxinity Inc (VAXX) has released an update.

Vaxxinity, Inc. received notice from Nasdaq that its stock doesn’t meet the minimum bid price rule for continued listing. The company has until August 7, 2024, to boost its share price back to at least $1.00 for ten consecutive days. While its stock remains listed during this period, Vaxxinity is exploring options to meet the requirement, with no certainty of success.

For further insights into VAXX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyVaxxinity’s Parkinson’s candidate UB-312 demonstrates efficacy in publication
GlobeNewswireVaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
GlobeNewswireVaxxinity Issues Shareholder Letter
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App